Only Cx26 and Cx43 have classically been described as tumour suppressors in the breast based on loss of expression in many mammary tumor cell lines and the fact that ectopic re-expression of these connexins reverts some tumor cells into a more differentiated phenotype both in vitro and in vivo [11, 12, 16, 17]. This evidence concerns the gene GJB2 and neoplasm.